When you start semaglutide therapy, your body's chemistry shifts in measurable ways
When leg muscle mass declines, as can happen on GLP-1 therapy without adequate protein or exercise, insulin sensitivity can paradoxically worsen even as body weight falls
Precision Peptide testing transforms guesswork into data-driven personalization
In practice, however, many patients are prescribed the drug with little additional support, and a significant number stop treatment early
Get it wrong and you risk injecting degraded medication that has lost potency, or worse, medication that has become contaminated
The primary risks of Tirzepatide include gastrointestinal distress, such as nausea, diarrhea, and stomach pain, particularly when increasing the dose